Clinical Hepatocellular Carcinoma

The molecular targets of interest have expanded from angiogenesis to cancer cell-directed oncogenic signaling pathways for advanced HCC treatment. The feasibility of combining locoregional therapies and targeted agents, and the use of novel agents after curative treatments are currently under active investigation. Finally, the therapeutic strategy has shifted from monotherapy to combination targeted therapy.

  • Partial Hepatectomy
  • Clinical Analysis of Cells
  • Intra - arterial Chemotherapy
  • AFP Blood Testing

Related Conference of Clinical Hepatocellular Carcinoma

May 26-26, 2021

International Conference on Hepatitis

London, UK
June 14-15, 2021

7th International Conference on Hepatology

Osaka, Japan
June 14-15, 2021

International Conference on Gastroenterology and Liver

Amsterdam, Netherlands
June 14-15, 2021

International Congress on Viral Hepatitis

Rome, Italy
July 13-14, 2021

International Conference on Hepatitis & Liver diseases

Shanghai, Australia
July 20-21, 2021

20th World Gastroenterologists Summit

Osaka, Japan
August 05-06, 2021

Global Congress on Pancreas

Zurich, Switzerland
September 27-28, 2021

8th Global Conference on Mass Spectrometry

Tokyo, Japan
September 28-29, 2021

2 nd World Congress on Oil and Gas Engineering

Auckland, Newzealand
November 23-24, 2021

World Conference on Digestive and metabolic diseases

Hanoi, Vietnam

Clinical Hepatocellular Carcinoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in